This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180516006359/en/
Technavio has published a new market research report on the global brachytherapy devices market from 2018-2022. (Graphic: Business Wire)
Cancer leads to a change in the morphology of the human cells, as it leads to uncontrolled division of cells. There are more than 80 types of cancers. Cancer has a major impact on the health and well-being of individuals worldwide. In countries such as the US, in 2016, nearly 1.7 million new cases of cancer were diagnosed, and the most common type of cancers were pancreatic cancer, leukemia, kidney and renal pelvis cancer, bladder cancer, melanoma of the skin, colon and rectum cancer, breast cancer, prostate cancer, lung and bronchus cancer, thyroid cancer, endometrial cancer, and non-Hodgkin lymphoma. Globally, cancer is identified as one of the leading causes of death.
In this report, Technavio highlights the increasing focus on image-guided brachytherapy as one of the key emerging trends in the global brachytherapy devices market:
Increasing focus on image-guided brachytherapy
After the inception of brachytherapy, numerous innovations have been observed in brachytherapy. IGBT is one such significant innovation. IGBT uses advanced imaging techniques leading to more safe, accurate, and effective placement of the brachytherapy catheters. Furthermore, IGBT uses cross-sectional image data and lead to the development of 3D models, helping clinicians to accurately deliver radiation at the target site and also reduces the exposure to surrounded healthy tissues.
“Companies such as Varian Medical Systems support IGBT and offers solutions such as Varian BrachyTherapy Suite from the collaboration between Varian Medical Systems and Siemens to image and treat in the same room for brachytherapy procedures. It streamlines the workflow and avoids patient movement. In addition, it potentially reduces treatment errors,” says a senior analyst at Technavio for research on .
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Global brachytherapy devices market segmentation
The gynecological cancer segment held the largest market share in 2017, accounting for nearly 45% of the market. Cancers that affect women's reproductive organs are known as gynecological cancers, which include cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, and vulvar cancer. Women are at risk of developing various gynecological cancers, and the risk increases with age.
The Americas was the leading region for the global brachytherapy devices market in 2017, accounting for a market share of nearly 48%. By 2022, APAC and EMEA are expected to witness positive growth in terms of market share.
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180516006359/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: TECHNOLOGY OTHER TECHNOLOGY HEALTH MEDICAL DEVICES ONCOLOGY RESEARCH SCIENCE
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 05/16/2018 03:16 PM/DISC: 05/16/2018 03:16 PM